Clinical Trials Browser

OTHER × Inflammatory Breast Neoplasms × nintedanib × Clear all

NCT02389764 2019-07-17

Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC)

Phase 2 Terminated

10 enrolled 9 charts

Breast Neoplasms, Inflammatory Breast Neoplasms